The addition of L-GSH to granulomas from BCG-vaccinated subjects lead to increased CD4 T cell viability, increased TNF-α and IFN-γ production, decreased PD-1 expression, and diminished T cell exhaustion. This evidence concerns the gene IFNG and Granuloma.